natgillin/translations-raw huggingface dataset:
II.2.2. was, during the period commencing three months prior to the date of collection of the semen in this consignment until the date of its dispatch, situated in an area not restricted due to an outbreak of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, and vesicular stomatitis;
II.2.2. se, u razdoblju koje je započelo tri mjeseca prije datuma sakupljanja sjemena iz ove pošiljke do datuma otpreme, nalazio na području za koje nisu bile uvedene mjere zabrane zbog izbijanja slinavke i šapa, klasične svinjske kuge, afričke svinjske kuge, vezikularne bolesti svinja i vezikularnog stomatitisa;
II.2.3. was, during the period commencing 30 days prior to the date of collection of the semen in this consignment until the date of its dispatch, free from brucellosis and Aujeszky's disease;
II.2.3. je, u razdoblju koje je započelo 30 dana prije datuma sakupljanja sjemena iz ove pošiljke do datuma otpreme, bio bez bruceloze i bolesti Aujeszkoga;
(1)either <;CCOC3~[II.2.4. contains only animals that have not been vaccinated against Aujeszky's disease and meet the requirements of Annex B to Directive 90/429/EEC.]~CCOC3>;
(1)bilo <;CCOC3~[II.2.4. sadrži samo životinje koje nisu cijepljene protiv bolesti Aujeszkoga i koje ispunjavaju zahtjeve Priloga B Direktive 90/429/EEZ.]~CCOC3>;
(1)(3)and/or <;CCOC4~[II.2.4. is a centre in which some or all of the animals have been vaccinated against Aujeszky's disease using a gE deleted vaccine and meet the requirements of Annex B to Directive 90/429/EEC.]~CCOC4>;
(1)(3)i/ili <;CCOC4~[II.2.4. jest centar u kojemu su neke ili sve životinje cijepljene protiv bolesti Aujeszkoga cjepivom s uklonjenim glikoproteinom gE te ispunjavaju zahtjeve Priloga B Direktive 90/429/EEZ.]~CCOC4>;
Conditions for the admission of animals to the semen collection centre
Uvjeti za primanje životinja u centar za sakupljanje sjemena
II.3. Prior to be admitted to the semen collection centre, all animals:
II.3. Prije primanja u centar za sakupljanje sjemena, sve životinje:
II.3.1. were subjected to a period of quarantine of at least 30 days in accommodation specifically approved for the purpose by the competent authority, and where only animals having at least the same health status were present (quarantine accommodation);
II.3.1. bile su u karanteni najmanje 30 dana u objektima koje je nadležno tijelo odobrilo isključivo u tu svrhu i u kojima su se nalazile samo životinje barem jednakoga zdravstvenog stanja (karantenski smještaj);
II.3.2. prior to entering the quarantine accommodation, were chosen from herds or holdings:
II.3.2. prije ulaska u karantenski smještaj odabrane su iz stada ili gospodarstava:
II.3.2.1. which were free of brucellosis in accordance with the Chapter on porcine brucellosis of the Terrestrial Animal Health Code of the World Organisation for Animal Health (OIE);
II.3.2.1. u kojima nije bilo bruceloze u skladu s Poglavljem o brucelozi svinja Priručnika za zdravlje kopnenih životinja Svjetske organizacije za zdravlje životinja (OIE);
II.3.2.2. in which no animal vaccinated against foot and-mouth disease was present in the preceding 12 months;
II.3.2.2. u kojima u prethodnih 12 mjeseci nije bilo životinja cijepljenih protiv slinavke i šapa;
II.3.2.3. which were not situated in a restricted area defined under the provisions of the national legislation due to an outbreak of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease;
II.3.2.3. koja se nisu nalazila na području za koje su uvedene mjere zabrane prema odredbama nacionalnog zakonodavstva zbog izbijanja slinavke i šapa, klasične svinjske kuge, afričke svinjske kuge, vezikularne bolesti svinja, vezikularnog stomatitisa i bolesti Aujeszkoga;
II.3.2.4. in which no clinical, serological, virological or pathological evidence of Aujeszky's disease was detected in the preceding 12 months;
II.3.2.4. u kojima u prethodnih 12 mjeseci nije zabilježen nikakav klinički, serološki, virološki ili patološki dokaz bolesti Aujeszkoga;
II.3.3. prior to entering the quarantine accommodation, were not previously kept in any herd of a lower health status than described in II.3.2.;
II.3.3. prije ulaska u karantenski smještaj nisu prethodno držane u stadu lošijeg zdravstvenog stanja od onoga opisanoga u točki II.3.2.;
II.3.4. within 30 days prior to entering the quarantine accomodation referred to in point II.3.1., were subjected to the following tests, performed in accordance with international standards, with negative results:
II.3.4. unutar 30 dana prije ulaska u karantenski smještaj naveden u točki II.3.1. bile su podvrgnute sljedećim testovima, provedenima u skladu s međunarodnim standardima, s negativnim rezultatima:
II.3.4.1. as regards brucellosis, a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA;
II.3.4.1. što se tiče bruceloze, testu s puferiranim Brucella antigenom (Rose Bengal test) ili testu cELISA ili iELISA;
II.3.4.2. as regards Aujeszky's disease,
II.3.4.2. što se tiče bolesti Aujeszkoga,
(1)either <;RCOC5~[II.3.4.2.1. in the case of non-vaccinated animals, a serum neutralisation test or an ELISA for detecting antibodies to the whole Aujeszky's disease virus or to its glycoprotein B (ADV-gB) or glycoprotein D (ADV-gD);]~RCOC5>;
(1)bilo <;RCOC5~[II.3.4.2.1. u slučaju životinja koje nisu cijepljene, serum-neutralizacijskom testu ili testu ELISA za dokazivanje protutijela na cijeli virus bolesti Aujeszkoga ili na njegov glikoprotein B (ADV-gB) ili glikoprotein D (ADV-gD);]~RCOC5>;
(1)or <;RCOC6~[II.3.4.2.1. in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting antibodies to glycoprotein E (ADV-gE);]~RCOC6>;
(1)ili <;RCOC6~[II.3.4.2.1. u slučaju životinja cijepljenih cjepivom s uklonjenim glikoproteinom gE, testu ELISA za dokazivanje protutijela na glikoprotein E (ADV-gE);]~RCOC6>;
(1)either <;RCOC7~[II.3.5. were admitted to the centre after all of the animals had reacted with negative result to a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA carried out on samples collected during the last 15 days of the period of quarantine specified in point II.3.1.;]~RCOC7>;
(1)bilo <;RCOC7~[II.3.5. primljene su u centar nakon što su sve životinje postigle negativan rezultat na testu s puferiranim Brucella antigenom (Rose Bengal test) ili testu cELISA ili iELISA provedenom na uzorcima sakupljenima tijekom zadnjih 15 dana razdoblja karantene navedenog u točki II.3.1.;]~RCOC7>;
(1)or <;RCOC8~[II.3.5. were admitted to the centre after not all of the animals had reacted with negative result to a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA carried out on samples collected during the last 15 days of the period of quarantine specified in point II.3.1. and the suspicion of brucellosis was ruled out in accordance with point 1.5. of Chapter I of Annex B to Directive 90/429/EEC;]~RCOC8>;
(1)ili <;RCOC8~[II.3.5. primljene su u centar nakon što nisu sve životinje postigle negativan rezultat na testu s puferiranim Brucella antigenom (Rose Bengal test) ili testu cELISA ili iELISA provedenom na uzorcima sakupljenima tijekom zadnjih 15 dana razdoblja karantene navedenog u točki II.3.1. te je sumnja na brucelozu isključena sukladno točki 1.5. Poglavlja I. Priloga B Direktive 90/429/EEZ;]~RCOC8>;
II.3.6. were subjected to the following tests for Aujeszky's disease carried out on samples collected during the last 15 days of the period of quarantine specified in point II.3.1.:
II.3.6. podvrgnute su sljedećim testovima na bolest Aujeszkoga provedenima na uzorcima sakupljenima tijekom posljednjih 15 dana razdoblja karantene navedenog u točki II.3.1.:
(1)either <;RCOC9~[II.3.6.1. in the case of non-vaccinated animals, a serum neutralisation test or an ELISA for detecting antibodies to the whole Aujeszky's disease virus or to its glycoprotein B (ADV-gB) or glycoprotein D (ADV-gD);]~RCOC9>;
(1)bilo <;RCOC9~[II.3.6.1. u slučaju životinja koje nisu cijepljene, serum-neutralizacijskom testu ili testu ELISA za dokazivanje protutijela na cijeli virus bolesti Aujeszkoga ili na njegov glikoprotein B (ADV-gB) ili glikoprotein D (ADV-gD);]~RCOC9>;
(1)or <;RCOC10~[II.3.6.1. in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting antibodies to glycoprotein E (ADV-gE);]~RCOC10>;
(1)ili <;RCOC10~[II.3.6.1. u slučaju životinja cijepljenih cjepivom s uklonjenim glikoproteinom gE, testu ELISA za dokazivanje protutijela na glikoprotein E (ADV-gE);]~RCOC10>;
(1)either <;RCOC11~[II.3.6.2. the tests referred to in point II.3.6.1. were carried out with negative result in each case;]~RCOC11>;
(1)bilo <;RCOC11~[II.3.6.2. testovi navedeni u točki II.3.6.1. provedeni su s negativnim rezultatom u svakom slučaju;]~RCOC11>;
(1)or <;RCOC12~[II.3.6.2. the animals that proved positive in a test referred to in point II.3.6.1. were removed immediately from the quarantine accommodation and the competent authority took all necessary measures to ensure that the remaining animals had a satisfactory health status before being admitted to the collection centre in accordance with point II.3.;]~RCOC12>;
(1)ili <;RCOC12~[II.3.6.2. životinje s pozitivnim rezultatom u testu navedenom u točki II.3.6.1. odmah su uklonjene iz karantenskog smještaja, a nadležno je tijelo poduzelo sve potrebne mjere kako bi osiguralo zadovoljavajuće zdravstveno stanje preostalih životinja prije primanja u centar za sakupljanje sukladno točki II.3.;]~RCOC12>;
II.3.7. All tests were carried out in a laboratory approved by the competent authority;
II.3.7. Svi su testovi provedeni u laboratoriju koji je odobrilo nadležno tijelo;
II.3.8. Animals were only admitted to the semen collection centre with the express permission of the centre veterinarian and all animal movements, entering and exiting the semen collection centre, are recorded;
II.3.8. Životinje su primljene u centar za sakupljanje sjemena samo uz izričito odobrenje veterinara tog centra, a sva su kretanja životinja, ulaženje i izlaženje iz centra za sakupljanje sjemena, zabilježena;
II.3.9. No animal admitted to the semen collection centre showed any clinical sign of disease on the day of admission; all animals came directly from the quarantine accommodation which, on the day of consignment and during the period of residency of the animals, officially fulfilled the following conditions:
II.3.9. Nijedna životinja primljena u centar za sakupljanje sjemena na dan primanja nije pokazivala kliničke znakove bolesti; sve su životinje stigle izravno iz karantenskog smještaja, koji je, na dan pošiljke i tijekom razdoblja boravka životinja, službeno ispunjavao sljedeće uvjete:
II.3.9.1. it was not situated in a restricted area defined under the provisions of national legislation due to an outbreak of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease;
II.3.9.1. nije se nalazio na području za koje su uvedene mjere zabrane prema odredbama nacionalnog zakonodavstva zbog izbijanja slinavke i šapa, klasične svinjske kuge, afričke svinjske kuge, vezikularne bolesti svinja, vezikularnog stomatitisa i bolesti Aujeszkoga;
II.3.9.2. no clinical, serological, virological or pathological evidence of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease had been recorded for the past 30 days.
II.3.9.2. posljednjih 30 dana nije zabilježen klinički, serološki, virološki ili patološki dokaz slinavke i šapa, klasične svinjske kuge, afričke svinjske kuge, vezikularne bolesti svinja, vezikularnog stomatitisa i bolesti Aujeszkoga.
Compulsory routine tests for animals kept at the semen collection centre
Obvezni rutinski testovi za životinje koje se nalaze u centru za sakupljanje sjemena
II.4. All animals kept at the semen collection centre are subjected to the following routine tests carried out in a laboratory approved by the competent authority:
II.4. Sve životinje koje se nalaze u centru za sakupljanje sjemena podvrgnute su sljedećim rutinskim testovima koji se provode u laboratoriju koji je odobrilo nadležno tijelo:
II.4.1. as regards brucellosis, a buffered Brucella antigen test (rose Bengal test), or a cELISA or an iELISA;
II.4.1. što se tiče bruceloze, testu s puferiranim Brucella antigenom (Rose Bengal test) ili testu cELISA ili iELISA;
II.4.2. as regards Aujeszky's disease,
II.4.2. što se tiče bolesti Aujeszkoga,
(1)either <;RCOC13~[II.4.2.1. in the case of non-vaccinated animals, a serum neutralisation test or an ELISA for detecting antibodies to the whole Aujeszky's disease virus or to its glycoprotein B (ADV-gB) or glycoprotein D (ADV-gD); ]~RCOC13>;
(1)bilo <;RCOC13~[II.4.2.1. u slučaju životinja koje nisu cijepljene, serum-neutralizacijskom testu ili testu ELISA za dokazivanje protutijela na cijeli virus bolesti Aujeszkoga ili na njegov glikoprotein B (ADV-gB) ili glikoprotein D (ADV-gD); ]~RCOC13>;
(1)or <;RCOC14~[II.4.2.1. in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting antibodies to glycoprotein E (ADV-gE); ]~RCOC14>;
(1)ili <;RCOC14~[II.4.2.1. u slučaju životinja cijepljenih cjepivom s uklonjenim glikoproteinom gE, testu ELISA za dokazivanje protutijela na glikoprotein E (ADV-gE); ]~RCOC14>;
II.4.3. The routine tests referred to in points II.4.1. and II.4.2. are carried out on samples taken in accordance with point 1.2. of Chapter II of Annex B to Directive 90/429/EEC in order to ensure that all animals in the center have been tested at least once during their stay at that centre and at least every 12 months from the date of admission, if their stay exceeds 12 months;
II.4.3. Rutinski testovi navedeni u točkama II.4.1. i II.4.2. provode za na uzorcima uzetima u skladu s točkom 1.2. Poglavlja II. Priloga B Direktive 90/429/EEZ kako bi se osiguralo da su sve životinje u centru testirane barem jednom tijekom njihova boravka u centru te najmanje svakih 12 mjeseci od datuma primanja, ako trajanje njihova boravka iznosi više od 12 mjeseci;
(1)either <;RCOC15~[II.4.4. All of the animals have reacted with negative results in the routine tests referred to in points II.4.1. and II.4.2. carried out on samples referred to in point II.4.3.]~RCOC15>;
(1)bilo <;RCOC15~[II.4.4. Sve su životinje postigle negativne rezultate u rutinskim testovima navedenima u točkama II.4.1. i II.4.2. provedenima na uzorcima navedenima u točki II.4.3.]~RCOC15>;
(1)or <;RCOC16~[II.4.4. Not all of the animals have reacted with negative results in the tests referred to in points II.4.1. and II.4.2. carried out on samples referred to in point II.4.3.:
(1)ili <;RCOC16~[II.4.4. Nisu sve životinje postigle negativne rezultate na testovima navedenima u točkama II.4.1. i II.4.2. provedenima na uzorcima navedenima u točki II.4.3.:
(a) the animals which proved positive were isolated,
(a) životinje s pozitivnim rezultatima bile su izolirane,
(b) the semen collected from each animal at the centre since the date of that animal's last negative test was held in separate storage from semen eligible for export to the European Union which was collected before the animal's last negative test or after the health status of the centre had been re-established under responsibility of the competent authority of the exporting coutry.
(b) sjeme sakupljeno od svake životinje u centru od datuma posljednjeg negativnog testa te životinje zasebno je skladišteno od sjemena namijenjenog za izvoz u Europsku uniju koje je sakupljeno prije posljednjeg negativnog testa životinje ili nakon što je zdravstveni status centra ponovno uspostavljen pod odgovornošću nadležnog tijela države izvoznice.
Conditions for semen collected at a semen collection centre and intended for export to the Union
Uvjeti za sjeme sakupljeno u centru za sakupljanje sjemena i namijenjeno za izvoz u Uniju
II.5. The semen in this consignment was obtained from animals which:
II.5. Sjeme u ovoj pošiljci dobiveno je od životinja koje:
II.5.1. have been resident in <;AB3>; (name of third country(2)) for a minimum period of three months immediately prior to collection;
II.5.1. su boravile u <;AB3>; (naziv treće zemlje(2)) minimalno tri mjeseca neposredno prije sakupljanja;
II.5.2. showed no clinical signs of disease on the day the semen was collected;
II.5.2. na dan kada je sjeme sakupljeno nisu pokazivale kliničke znakove bolesti;
II.5.3. had not been vaccinated against foot-and-mouth disease;
II.5.3. nisu cijepljene protiv slinavke i šapa;
II.5.4. satisfy the requirements referred to in point II.3.;
II.5.4. udovoljavaju zahtjevima navedenima u točki II.3.;
II.5.5. have not been allowed to serve naturally;
II.5.5. nije im dopušteno prirodno parenje;
II.5.6. were kept in semen collection centres which were not situated in a restricted area designated under the provisions of the national legislation relating to foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease;
II.5.6. su držane u centrima za sakupljanje sjemena koji se ne nalaze na području za koje su uvedene mjere zabrane prema odredbama nacionalnog zakonodavstva povezane sa slinavkom i šapom, klasičnom svinjskom kugom, afričkom svinjskom kugom, vezikularnom bolesti svinja, vezikularnim stomatitisom i bolesti Aujeszkoga;
II.5.7. were kept in semen collection centres in which no clinical, serological, virological or pathological evidence of foot-and-mouth disease, classical swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's disease has been detected in the 30-day period immediately prior to collection.
II.5.7. su držane u centrima za sakupljanje sjemena u kojima nije pronađen klinički, serološki, virološki ili patološki dokaz slinavke i šapa, klasične svinjske kuge, afričke svinjske kuge, vezikularne bolesti svinja, vezikularnog stomatitisa i bolesti Aujeszkoga u razdoblju od 30 dana prije sakupljanja.
II.6. An effective combination of antibiotics, in particular against leptospires, was added to the semen in this consignment after final dilution or to the diluent.
II.6. Učinkovita kombinacija antibiotika, naročito protiv leptospiroze, dodana je sjemenu u ovoj pošiljci nakon konačnog razrjeđivanja ili razrjeđivaču.
In the case of frozen semen, antibiotics were added before the semen was frozen.
U slučaju smrznutog sjemena, antibiotici su dodani prije smrzavanja sjemena.
II.6.1. The combination of antibiotics referred to in point II.6. produced an effect at least equivalent to the following concentration in the final diluted semen:
II.6.1. Kombinacija antibiotika navedena u točki II.6. postigla je učinak barem jednak sljedećoj koncentraciji u konačno razrijeđenom sjemenu.
(a) not less than 500 μg streptomycin per ml final dilution,
(a) najmanje 500 μg streptomicina po ml konačno razrijeđenog sjemena,
(b) not less than 500 IU penicillin per ml final dilution,
(b) najmanje 500 IU penicilina po ml konačno razrijeđenog sjemena,
(c) not less than 150 μg lincomycin per ml final dilution,
(c) najmanje 150 μg lincomicina po ml konačno razrijeđenog sjemena,
(d) not less than 300 μg spectinomycin per ml final dilution;
(d) najmanje 300 μg spektinomicina po ml konačno razrijeđenog sjemena;
II.6.2. Immediately after the addition of the antibiotics the diluted semen was kept at a temperature of at least 15°C for a period of not less than 45 minutes.
II.6.2. Odmah nakon dodavanja antibiotika razrijeđeno je sjeme čuvano na temperaturi od najmanje 15 °C tijekom najmanje 45 minuta.
II.7. The semen in this consignment:
II.7. Sjeme u ovoj pošiljci:
II.7.1. has been stored as laid down in point 2(d) of Chapter I and point 6(a), (b), (e) and (f) of Chapter II of Annex A to Directive 90/429/EEC prior to dispatch;
II.7.1. čuvano je kako je navedeno u točki 2. (d) Poglavlja I. i točkama 6(a), (b), (e) i (f) Poglavlja II. Priloga A Direktive 90/429/EEZ prije otpreme;
II.7.2. is being transported to the country of destination in flasks which were cleaned and disinfected or sterilised before use and which have been sealed prior to dispatch from the approved storage facilities.
II.7.2. prevozi se u državu odredišta u bocama koje su očišćene i dezinficirane ili sterilizirane prije uporabe te koje su zapečaćene prije otpreme iz odobrenih objekata za skladištenje.
Box I.8.: Provide the code of the third country as appearing in Annex I to Decision 2012/137/EU.
Rubrika I.8.: Navesti kod treće zemlje koji se nalazi u Prilogu I. Odluke 2012/137/EU.
Box I.11.: Place of origin shall correspond to the semen collection centre of the semen dispatch listed in accordance with Article 8(2) of Directive 90/429/EEC:
Rubrika I.11.: Mjesto podrijetla mora odgovarati centru za sakupljanje sjemena koji otprema sjeme navedenom u skladu s člankom 8(2) Direktive 90/429/EEZ:
Box I.12.: Place of destination:
Rubrika I.12.: Mjesto odredišta:
Box I.22.: Number of packages shall correspond to the number of containers.
Rubrika I.22.: Broj paketa mora odgovarati broju kontejnera.
Box I.28.: Donor identity shall correspond to the official identification of the animal.
Rubrika I.28.: identifikacijska oznaka mora odgovarati identifikacijskoj oznaci životinje donora.
Approval number of the centre shall correspond to the approval number of the semen collection centre where the semen was collected.
Odobreni broj centra mora odgovarati odobrenom broju centra za sakupljanje sjemena u kojemu je sjeme sakupljeno.
(2) Countries listed in Annex I to Decision 2012/137/EU.
(2) Države navedene u Prilogu I. Odluke 2012/137/EU.
(3) This option shall be deleted in case the Member State, or a region thereof, of destination is free of Aujeszky's disease in accordance with Article 10 of Directive 64/432/EEC, has informed the Commission in accordance with point 4 of Annex C to Directive 90/429/EEC and is listed on the following website:
(3) Ovu opciju precrtati u slučaju da je država članica, ili njezina regija, odredišta slobodna od bolesti Aujeszkoga u skladu s člankom 10. Direktive 64/432/EEZ, obavijestila je o tome Komisiju u skladu s točkom 4. Priloga C Direktive 90/429/EEZ te je navedena na sljedećoj internetskoj stranici:
II.1.2. have not received:
II.1.2. nisu tretirane:
- oestrogenic, androgenic, gestagenic or - agonist substances for purposes other than therapeutic or zootechnic treatment (as defined in Directive 96/22/EC);
- estrogenim, androgenim, gestagenim tvarima ili β-agonistima u druge svrhe, osim u cilju terapije ili zootehničke svrhe (kako je definirano u Direktivi Vijeća 96/22/EZ);
II.1.3. with regard to bovine spongiform encephalopathy (BSE):
II.1.3. vezano za goveđu spongiformnu encefalopatiju (GSE:
(1)(2) either <;RCOC1~[(a) the animals are identified by a permanent identification system enabling them to be traced back to the dam and herd of origin, and are not exposed bovine animals as described in Chapter C, part I, point (4) (b) (iv) of Annex II of Regulation (EC) No 999/2001;
(1)(2) bilo <;RCOC1~[(a) da su životinje označene trajnim načinom označavanja koje omogućava sljedivost do majke i stada podrijetla te da nisu izložene govedima kako je opisano u Poglavlju C, Dijelu I., točki (4) (b) (iv) Priloga II. Uredbe (EZ) br.
(b) if there have been BSE indigenous cases in the country concerned, the animals were born after the date from which the ban on the feeding of ruminants with meat-and-bone meal and greaves derived from ruminants had been effectively enforced or after the date of birth of the last BSE indigenous case if born after the date of the feed ban.]~RCOC1>;
(b) ako je u dotičnoj državi bilo autohtonih slučajeva GSE-a životinje su rođene nakon datuma učinkovitog uvođenja zabrane hranjenja preživača mesno-koštanim brašnom i čvarcima dobivenim od preživača ili nakon datuma rođenja posljednje životinje inficirane GSE-om, ako je životinja rođena nakon datuma uvođenja zabrane hranjenja.]~RCOC1>;